Regression of gadolinium-enhanced lesions in patients affected by neurofibromatosis type 1
- 165 Downloads
Neurofibromatosis type I is a genetic condition with an autosomal dominant transmission characterized by neurocutaneous involvement and a predisposition to tumor development. Central nervous system manifestations include benign areas of dysmyelination and possibly hazardous glial tumors whose clinical management may result challenging. Here, we report on three patients diagnosed with Neurofibromatosis type I whose brain MRI follow-up showed the presence of gadolinium-enhancing lesions which spontaneously regressed. In none of the three cases, the lesions showed any clinical correlate and eventually presented a striking reduction in size while gadolinium enhancement disappeared despite no specific therapy administration during the follow-up. Although their nature remains undetermined, these lesions presented a benign evolution. However, they might be misdiagnosed as potentially life-threatening tumors. Hitherto, a similar behavior has been described only in scattered cases and we believe these findings may be of particular interest for the clinical management of patients affected by neurofibromatosis type I.
KeywordsNeurofibromatosis type 1 Gliomas Gadolinium Lesions Magnetic resonance imaging
Compliance with ethical standards
Conflict of interest
None of the authors have conflict of interests to disclose.
The manuscript does not contain clinical studies, no Ethics Committee approval was necessary.
- 2.Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181–186CrossRefPubMedGoogle Scholar
- 12.Margari L, Presicci A, Ventura P, Maria Bacca S, Iliceto G, Medicamento N, Buttiglione M, Perniola T (2006) Clinical and instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1. J Child Neurol 21:1085–1090CrossRefPubMedGoogle Scholar
- 14.NIH-consensus-statement. Neurofibromatosis. Conference statement (1988). National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578Google Scholar